skip to main |
skip to sidebar
Hot Topics of the Day|PHGKB
Last Posted: Feb 26, 2020
- Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Yanes Tatiane et al. Breast cancer research : BCR 2020 Feb 22(1) 21
- Genome-Wide Polygenic Score and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study.
Emdin Connor A et al. Circulation. Genomic and precision medicine 2020 Feb (1) e002767
- Do Polygenic Risk Scores Improve Patient Selection for Prevention of Coronary Artery Disease?
SS Khan et al, JAMA Editorial, February 18, 2020
- Opportunities and Challenges for Polygenic Risk Scores in Prognostication and Prevention of Cardiovascular Disease
CJ O'Donnell, JAMA Cardiology, February 12, 2020
- Promises and perils of using genetic tests to predict risk of disease
IA Scott et al, BMJ, February 2020
- Integration of polygenic risk scores with modifiable risk factors improves risk prediction: results from a pan-cancer analysis
BioRXIV, January 30, 2020
- Predicting Atrial Fibrillation using a Combination of Genetic Risk Score and Clinical Risk Factors.
Okubo Yousaku et al. Heart rhythm 2020 Jan
- Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations
Notice of Special Interest, January 13, 2020
- Polygenic Risk, Fitness, and Obesity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study
VL Murthy et al, JAMA Cardiology, January 8, 2020
- A Genetic Risk Score for the Estimation of Weight Loss After Bariatric Surgery.
Katsareli E A et al. Obesity surgery 2020 Jan
Hot Topics of the Day|PHGKB
Last Posted: Feb 27, 2020
- Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers.
Eskes Eline C B et al. Molecular genetics and metabolism 2020 Feb
- Making Informed CHOICES: The Launch of a "Big Data" Pragmatic Trial to Improve Cholesterol Management and Prevent Heart Disease in Ontario.
Ferreira-Legere Laura E et al. Healthcare quarterly (Toronto, Ont.) 2020 Jan 22(4) 6-9
- Aspirin for Prevention of Cardiovascular Disease
AT Peters et al, JAMA Patient Page, February 18, 2020
- Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
Yarmolinsky James et al. JAMA 2020 Feb 323(7) 646-655
- Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
M Trinder et al, JAMA Cardiology, February 11, 2020
- Autosomal recessive hypercholesterolemia: update for 2020.
D'Erasmo Laura et al. Current opinion in lipidology 2020 Jan
- Familial hypercholesterolemia: Detect, treat, and ask about family.
Shah Nishant P et al. Cleveland Clinic journal of medicine 2020 Feb 87(2) 109-120
- Efficacy of therapeutic lifestyle changes on lipid profiles assessed by NMR in children with familial and non-familial hypercholesterolemia.
Rodríguez-Borjabad Cèlia et al. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis 2020 Jan
- Step aside CRISPR, RNA editing is taking off: Making changes to the molecular messengers that create proteins might offer flexible therapies for cancer, pain or high cholesterol, in addition to genetic disorders.
S Reardon, Nature, February 4, 2020
- Familial Hypercholesterolaemia in 2020: A Leading Tier 1 Genomic Application.
Pang Jing et al. Heart, lung & circulation 2019 Dec